Bushu Pharma

Bushu Pharmaceuticals is a leading contract development and manufacturing organisation (CDMO) based in Japan, specialising in high-quality pharmaceutical and medical device solutions for global markets.

Founded in 1998 and headquartered in Kawagoe, Japan, Bushu Pharmaceuticals has established itself as a trusted partner in the pharmaceutical and healthcare industries. With a commitment to excellence, the company provides end-to-end CDMO services, including drug formulation, manufacturing, packaging, and distribution. Renowned for its adherence to Good Manufacturing Practices (GMP) and its advanced facilities, Bushu Pharmaceuticals serves clients worldwide, ensuring safety, quality, and regulatory compliance.

The company has developed a strong global footprint, exporting products to over 40 countries, including Europe, the United States, and Asia. Leveraging state-of-the-art technologies and a skilled workforce, Bushu Pharmaceuticals excels in delivering comprehensive solutions tailored to meet the needs of pharmaceutical companies, from small-scale clinical trials to large-scale commercial production.

Key Products and Services:

• Pharmaceutical Manufacturing: High-quality production of tablets, capsules, injectables, and sterile products.
• Packaging Services: Primary and secondary packaging solutions, including blister packs, bottles, and pouches.
• Clinical Trials and Technical Transfer: Expertise in supporting clinical trial materials and seamless product transfer from client facilities.
• Supply Chain Management: Efficient logistics, inventory management, and distribution services to ensure timely delivery.
• GATEWAY to ASIA: A specialised service helping international companies enter Asian markets, including regulatory support and supply chain solutions.
• Specialised Capabilities: High-potency drug handling, sterile manufacturing, and advanced quality assurance systems.

Bushu Pharmaceuticals continues to advance as a leader in the CDMO industry, driven by innovation, sustainability, and a customer-focused approach. With its strategic investments in cutting-edge technologies and commitment to global healthcare, the company is well-positioned to deliver trusted pharmaceutical solutions to its clients and improve patient outcomes worldwide.